Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of synthetic method of ularitide

A technology of uralitide and its synthetic method, which is applied in the field of medicine, can solve the problems of environmental protection that is not conducive to green chemistry, difficulty in dissolving uralitide, and unfavorable large-scale production, so as to shorten the oxidation reaction time, realize large-scale production, and facilitate operation Effect

Inactive Publication Date: 2020-02-04
HYBIO PHARMA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, using this scheme for oxidation, due to the difficulty in dissolving uraritide and the final oxidation needs to be carried out at a very dilute concentration, the operation is very difficult, and the reaction time is long, which is not conducive to large-scale production
In addition, this method will produce a large amount of mixed waste liquid of organic solvent and water, which is not conducive to the requirements of green chemistry in terms of environmental protection.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of synthetic method of ularitide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Example 1: N-methylimidazole ethanol tetrafluoroborate carrier [PEG 1 min][BF 4 ] preparation

[0047] Weigh 120mmol of N-methylimidazole, add equimolar amount of chloroethanol, heat to 80°C under microwave conditions, react for 10min, and stop the reaction to obtain N-methylimidazole ethanol chloride. N-methylimidazole ethanol chloride and ammonium tetrafluoroborate are ion-exchanged to obtain N-methylimidazole ethanol tetrafluoroboric acid carrier [PEG 1 min][BF 4 ] (reaction formula sees the content of the invention SCHEME 1).

Embodiment 2

[0048] Example 2: N-methylimidazole ethanol hexafluorophosphate carrier [PEG 1 min][PF 6 ] preparation

[0049] Referring to the method of Example 1, weigh 120 mmol of N-methylimidazole, add an equimolar amount of chloroethanol, heat to 80° C. under microwave conditions, react for 10 minutes, and stop the reaction to obtain N-methylimidazole ethanol chloride. Ion exchange of N-methylimidazole ethanol chloride and ammonium hexafluorophosphate to obtain N-methylimidazole ethanol hexafluorophosphate carrier [PEG 1 min][PF 6 ].

Embodiment 3

[0050] Example 3: Pyridine ethanol tetrafluoroborate carrier [PEG 1 py][BF 4 ] preparation

[0051] Referring to the method of Example 1, weigh 120 mmol of pyridine, add an equimolar amount of chloroethanol, heat to 80° C. under microwave conditions, react for 10 min, and stop the reaction to obtain pyridine alcohol chloride. Pyridyl alcohol tetrafluoroboric acid carrier [PEG 1 py][BF 4 ].

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicament, and discloses a synthetic method for ularitide. According to the synthetic method, the protected Tyr and an ionic liquid carrier are coupled under the action of a coupling system; according to the peptide sequence of the ularitide, residual protected amino acid is prepared through solid-phase synthesis, an ularitide linear peptide ionic liquid peptide carrier is obtained, and a linear peptide crude product is obtained through cracking; the linear peptide crude product is oxidized, and a disulfide bond-containing ularitide crude product is obtained; and the ularitide crude product is purified, and fine peptide is obtained. The room temperature ionic liquid carrier is used for replacing a resin carrier in traditional solid-phase synthesis and an organic solvent and water liquid phase oxidizing medium in the oxidization link, the purity of the crude peptide of the ularitide linear peptide obtained through solid-phase synthesis is obviously increased, meanwhile, the oxidization reaction time can be greatly shortened, operation is convenient, and generation of organic waste liquid is avoided.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a method for synthesizing ularitide. Background technique [0002] Ularitide is a natriuretic peptide isolated from human urine. Its analytical structure is similar to that of atrial natriuretic peptide, except that there are four more amino acid residues at the N-terminal of its sequence. Relevant studies have shown that Ularitide has various effects such as dilating blood vessels, dilating bronchi and diuresis, and has certain therapeutic effects on heart failure, renal failure, pulmonary hypertension and bronchial asthma clinically. [0003] The structure of Uralitide is a polypeptide composed of 32 amino acids containing a pair of intramolecular disulfide bonds, which is generally prepared by chemical synthesis. The sequence structure is: [0004] H-Thr-Ala-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly- Leu-Gly-Cys-Asn-Ser-Phe-Arg-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/58C07K1/06C07K1/04
CPCC07K14/58
Inventor 戴政清宓鹏程伍柯瑾陶安进袁建成
Owner HYBIO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products